Regulation And Legal
GlaxoSmithKline Pharmaceuticals Receives ₹3.54 Crore NPPA Demand
GlaxoSmithKline Pharmaceuticals received a ₹3.54 crore demand notice from the National Pharmaceutical Pricing Authority for alleged overcharging.
The demand comprises ₹1.23 crore for alleged overcharg
